Pathogenesis of bone lesions in rheumatoid arthritis.
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Histopathologic characterization of bone erosions from patients with rheumatoid arthritis (RA) and studies performed in animal models of inflammatory arthritis provide strong evidence that osteoclasts play an important role in focal marginal and subchondral bone loss in inflammatory arthritis. Much has been learned concerning the factors responsible for the induction and activation of osteoclasts associated with the bone erosions in RA. Therapies that target these osteoclast-inducing factors or other aspects of osteoclast-mediated bone resorption represent potential targets for blocking or at least attenuating bone destruction in RA. The demonstration of the role of the newly described osteoclastogenic factor receptor activator of nuclear factor kappaB ligand in RA synovial tissues and the successful prevention of bone erosions in animal models of arthritis with its inhibitor osteoprotegerin provide hope that specific therapies can be developed for preventing bone and joint destruction in RA, particularly in situations in which disease-modifying agents are ineffective in controlling disease activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“multiple forms of osteoclast-mediated bone loss that are characteristic of the disease, including focal bone erosions at the bone-pannus junction of inflamed joints, subchondral (periarticular) bone loss adjacent to inflamed joints, and generalized systemic bone loss (223-227).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [223]
In the citing paper
“Certainly the high circulating levels of TNF-␣ and IL-1 that are common in RA have the potential to promote osteoclastogenesis throughout the skeleton (223,237,(423)(424)(425).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [223]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,379
Research works printed but not linked: 4
- Gravallese EM, Goldring SR: Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000, 43:2143–2151. · doi:10.1002/1529-0131(200010)43:10<2143::aid-anr1>3.0.co;2-s
- Romas E, Bakharevski O, Hards DK, et al.: Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 2000, 43:821–826. In situ hybridization and histochemistry demonstrate osteoclasts at the bone pannus interface, and cells expressing RANKL mRNA. · doi:10.1002/1529-0131(200004)43:4<821::aid-anr12>3.0.co;2-t
- Gravallese EM, Manning C, Tsay A, et al.: Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000, 43:250–258. Activated T cells and synovial fibroblasts cultured from RA synovium express RANKL/ODF mRNA. · doi:10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p
- Takayanagi H, Iizuka H, Juji T, et al.: Involvement of receptor activator of nuclear factor kappa-B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43:259–269. Synovial fibroblasts produce RANKL/ODF and have the capacity in vitro to support osteoclastogenesis. · doi:10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w
Cited by
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
The Osteoclast: Friend or Foe?
Novack, D. V., & Teitelbaum, S. L. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151431 · Cited by 381
“In inflammatory osteolysis, such as occurs in rheumatic and psoriatic arthritis, osteoclasts erode periarticular bone in areas of active synovitis, resulting in joint collapse (Figure 8) (113).”
BackgroundAnakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
“1 24/355 5/299 20 (38) (23) (18) (7) (7) (2) Anakinra + Methotrexate + Etanercept vs Placebo + Methotrexate + Etanercept Genovese 200437 50/81 54/80 NA 25/81 33/80 NA 11/81 17/80 NA (62) (68) (31) (41) (14) (21) Totals (w/Genovese) 274/666 152/498 10 90/436 55/379 16.”
MethodThe inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis
Nakasa, T., Shibuya, H., Nagata, Y., Niimoto, T., & Ochi, M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30321 · Cited by 325
Metadata
- Authors
- Goldring, S. R., & Gravallese, E. M.
- Affiliations
- Harvard University (US)
- ORCID
- Gravallese, Ellen M.
- Venue
- Current Rheumatology Reports
- Published
- 2002-05
- Volume
- 4
- Issue
- 3
- Pages
- 226-231
- ISSN
- 1523-3774 (ISSN-L)
- 1534-6307
- OpenAlex
- W2997284754
- Cited by
- 44
- References
- 64
- Citations by year
- 2025: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Rheumatology Reports (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- rheumatoid arthritis, bone erosion, osteoclasts, bone resorption, subchondral bone loss, marginal bone loss, RANKL, osteoprotegerin, synovium, bone destruction, disease-modifying antirheumatic drugs, animal models of arthritis
- MeSH terms
- Arthritis, Rheumatoid, Bone Resorption, Humans, Osteoclasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis of bone lesions in rheumatoid arthritis. https://app.cochat.ai/papers/10.1007/s11926-002-0069-y
- The paper
- Goldring, S. R., & Gravallese, E. M. (2002). Pathogenesis of bone lesions in rheumatoid arthritis. Current Rheumatology Reports. https://doi.org/10.1007/s11926-002-0069-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.